Private Capital Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Northrop Grumman
NOC
|
+$7.97M |
| 2 |
JPMorgan Chase
JPM
|
+$7.83M |
| 3 |
AbbVie
ABBV
|
+$6.04M |
| 4 |
NVIDIA
NVDA
|
+$4.32M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$4.13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$8.91M |
| 2 |
DuPont de Nemours
DD
|
+$6.22M |
| 3 |
ExxonMobil
XOM
|
+$1.25M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$780K |
| 5 |
Fortive
FTV
|
+$486K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.55% |
| 2 | Technology | 17.29% |
| 3 | Communication Services | 13.62% |
| 4 | Industrials | 12.57% |
| 5 | Energy | 9.23% |
Similar funds
Private Capital Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, Private Capital Advisors held 104 positions worth $353M, up 6.9% from $330M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Private Capital Advisors deployed $20.2M of net new capital in Q2 2019, opening 6 new positions and adding to 21 existing holdings. Its largest new stake was Northrop Grumman: 26,750 shares worth $8.64M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 31% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was ExxonMobil, an estimated $1.25M trimmed.
- Private Capital Advisors's largest Q2 2019 buy was Northrop Grumman: 26,750 shares worth $8.64M.
- Private Capital Advisors added most to AbbVie in Q2 2019, an estimated $6.04M increase.
- Private Capital Advisors's biggest Q2 2019 reduction was ExxonMobil, cutting an estimated $1.25M.
- Private Capital Advisors fully exited iShares Biotechnology ETF in Q2 2019, selling an estimated $8.91M.
- Private Capital Advisors's ten largest holdings make up 40% of its $353M portfolio in Q2 2019.
- Private Capital Advisors opened 6 new positions and closed 10 in Q2 2019.
- Private Capital Advisors's portfolio value rose 6.9% quarter-over-quarter to $353M.
Based on Private Capital Advisors's 13F filing for Q2 2019, filed 18 Jul 2019.